Clinical Trial Update: A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a novel insulin lispro formulation in individuals with type 1 diabetes mellitus using insulin pumps has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin lispro (novel formulation) (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: WITHDRAWN